These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965 [TBL] [Abstract][Full Text] [Related]
6. Antibodies Elicited by the Micoli F; Rossi O; Conti V; Launay O; Sciré AS; Aruta MG; Nakakana UN; Marchetti E; Rappuoli R; Saul A; Martin LB; Necchi F; Podda A Front Immunol; 2021; 12():671325. PubMed ID: 34017343 [No Abstract] [Full Text] [Related]
7. Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine. Conti V; Rossi O; Clarkson KA; Mancini F; Nakakana UN; Sarakinou E; Callegaro A; Ferruzzi P; Acquaviva A; Arora AK; Marchetti E; Necchi F; Frenck RW; Martin LB; Kaminski RW; Podda A; Micoli F NPJ Vaccines; 2024 Mar; 9(1):56. PubMed ID: 38459072 [TBL] [Abstract][Full Text] [Related]
8. GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia. De Ryck I; Sarakinou E; Nakakana U; Cilio GL; Ndiaye A; Vella V; Auerbach J; Granada JP; Conti V; Podda A Infect Dis Ther; 2022 Apr; 11(2):757-770. PubMed ID: 35118580 [TBL] [Abstract][Full Text] [Related]
9. Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection. Talaat KR; Alaimo C; Martin P; Bourgeois AL; Dreyer AM; Kaminski RW; Porter CK; Chakraborty S; Clarkson KA; Brubaker J; Elwood D; Frölich R; DeNearing B; Weerts H; Feijoo BL; Halpern J; Sack D; Riddle MS; Fonck VG EBioMedicine; 2021 Apr; 66():103310. PubMed ID: 33862589 [TBL] [Abstract][Full Text] [Related]
10. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538 [TBL] [Abstract][Full Text] [Related]
16. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach. Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338 [TBL] [Abstract][Full Text] [Related]
20. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]